Form 4: STERIS plc Executive Acquires Shares and Options

Julia Madsen, Senior VP of Life Sciences at STERIS plc, reports acquisition of shares and stock options.

Summary

• Julia Madsen, a Senior VP at STERIS plc, filed a Form 4 with the SEC.
• The filing reports the acquisition of 1,626 ordinary shares at $0 price on June 4, 2024.
• Following the transaction, Madsen beneficially owns 9,671 ordinary shares.
• Madsen also acquired an option to buy 8,336 ordinary shares at an exercise price of $251.34, expiring on June 4, 2034.
• These options become exercisable in installments starting June 4, 2025.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it indicates confidence from a senior executive.

Positives

• The acquisition of shares and options by a senior executive could be interpreted as a positive signal about the executive's confidence in the company's future prospects.

Industry Context

Executive stock ownership is a common practice in publicly traded companies and is often used to align management's interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock, are standard practice among publicly traded companies like STERIS.
• Comparing the size of the option grant and share ownership to peers in the medical device and equipment industry would provide further context.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates